116 related articles for article (PubMed ID: 38350361)
21. Design and synthesis of novel 3-amino-5-phenylpyrazole derivatives as tubulin polymerization inhibitors targeting the colchicine-binding site.
Yang Y; Cao Y; Yu J; Yu X; Guo Y; Wang F; Ren Q; Li C
Eur J Med Chem; 2024 Mar; 267():116177. PubMed ID: 38280356
[TBL] [Abstract][Full Text] [Related]
22. A novel aromatic amide derivative SY-65 co-targeted tubulin and histone deacetylase 1 with potent anticancer activity in vitro and in vivo.
Li YR; Liu FF; Liu WB; Zhang YF; Tian XY; Fu XJ; Xu Y; Song J; Zhang SY
Biochem Pharmacol; 2022 Jul; 201():115070. PubMed ID: 35526597
[TBL] [Abstract][Full Text] [Related]
23. A comprehensive assessment of a new series of 5',6'-difluorobenzotriazole-acrylonitrile derivatives as microtubule targeting agents (MTAs).
Riu F; Sanna L; Ibba R; Piras S; Bordoni V; Scorciapino MA; Lai M; Sestito S; Bagella L; Carta A
Eur J Med Chem; 2021 Oct; 222():113590. PubMed ID: 34139625
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis and evaluation of antiproliferative and antitubulin activities of 5-methyl-4-aryl-3-(4-arylpiperazine-1-carbonyl)-4H-1,2,4-triazoles.
Wang C; Li Y; Liu T; Wang Z; Zhang Y; Bao K; Wu Y; Guan Q; Zuo D; Zhang W
Bioorg Chem; 2020 Nov; 104():103909. PubMed ID: 33142419
[TBL] [Abstract][Full Text] [Related]
25. Discovery of Novel Quinoline-Chalcone Derivatives as Potent Antitumor Agents with Microtubule Polymerization Inhibitory Activity.
Li W; Xu F; Shuai W; Sun H; Yao H; Ma C; Xu S; Yao H; Zhu Z; Yang DH; Chen ZS; Xu J
J Med Chem; 2019 Jan; 62(2):993-1013. PubMed ID: 30525584
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological evaluation of novel benzo[c]acridine-diones as potential anticancer agents and tubulin polymerization inhibitors.
Behbahani FS; Tabeshpour J; Mirzaei S; Golmakaniyoon S; Tayarani-Najaran Z; Ghasemi A; Ghodsi R
Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800307. PubMed ID: 31012156
[TBL] [Abstract][Full Text] [Related]
27. Induction of apoptosis through tubulin inhibition in human cancer cells by new chromene-based chalcones.
Aryapour H; Riazi GH; Ahmadian S; Foroumadi A; Mahdavi M; Emami S
Pharm Biol; 2012 Dec; 50(12):1551-60. PubMed ID: 22984888
[TBL] [Abstract][Full Text] [Related]
28. (E)-N-Aryl-2-oxo-2-(3,4,5-trimethoxyphenyl)acetohydrazonoyl cyanides as tubulin polymerization inhibitors: Structure-based bioisosterism design, synthesis, biological evaluation, molecular docking and in silico ADME prediction.
Wang G; Peng Z; Peng S; Qiu J; Li Y; Lan Y
Bioorg Med Chem Lett; 2018 Nov; 28(20):3350-3355. PubMed ID: 30197030
[TBL] [Abstract][Full Text] [Related]
29. Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure-activity relationships of the 4-aryl group.
Kemnitzer W; Drewe J; Jiang S; Zhang H; Wang Y; Zhao J; Jia S; Herich J; Labreque D; Storer R; Meerovitch K; Bouffard D; Rej R; Denis R; Blais C; Lamothe S; Attardo G; Gourdeau H; Tseng B; Kasibhatla S; Cai SX
J Med Chem; 2004 Dec; 47(25):6299-310. PubMed ID: 15566300
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, and biological evaluation of novel benzodiazepine derivatives as anticancer agents through inhibition of tubulin polymerization in vitro and in vivo.
Pang Y; Lin H; Ou C; Cao Y; An B; Yan J; Li X
Eur J Med Chem; 2019 Nov; 182():111670. PubMed ID: 31499359
[TBL] [Abstract][Full Text] [Related]
31. Characterization of novel heterocyclic compounds based on 4-aryl-4H-chromene scaffold as anticancer agents: Design, synthesis, antiprofilerative activity against resistant cancer cells, dual β-tubulin/c-Src inhibition, cell cycle arrest and apoptosis induction.
Abdelall EKA; A H Elshemy H; Labib MB; E A Mohamed F
Bioorg Chem; 2022 Mar; 120():105591. PubMed ID: 34998122
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of Combretastatin-A4 Carboxamidest that Mimic Sulfonyl Piperazines by a Molecular Hybridization Approach: in vitro Cytotoxicity Evaluation and Inhibition of Tubulin Polymerization.
Jadala C; Sathish M; Anchi P; Tokala R; Lakshmi UJ; Reddy VG; Shankaraiah N; Godugu C; Kamal A
ChemMedChem; 2019 Dec; 14(24):2052-2060. PubMed ID: 31674147
[TBL] [Abstract][Full Text] [Related]
33. Discovery of novel indole-1,2,4-triazole derivatives as tubulin polymerization inhibitors.
Wu MK; Man RJ; Liao YJ; Zhu HL; Zhou ZG
Drug Dev Res; 2021 Nov; 82(7):1008-1020. PubMed ID: 33675542
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and biological evaluation of 4-anilinoquinoline derivatives as novel potent tubulin depolymerization agents.
Zhou Y; Yan W; Cao D; Shao M; Li D; Wang F; Yang Z; Chen Y; He L; Wang T; Shen M; Chen L
Eur J Med Chem; 2017 Sep; 138():1114-1125. PubMed ID: 28763646
[TBL] [Abstract][Full Text] [Related]
35. 3-aryl-4-(3,4,5-trimethoxyphenyl)pyridines inhibit tubulin polymerisation and act as anticancer agents.
Wang C; Zhang Y; Yang S; Shi L; Xiu Y; Wu Y; Jiang H
J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2286939. PubMed ID: 38083880
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis and biological evaluation of novel pyrazoline-containing derivatives as potential tubulin assembling inhibitors.
Qin YJ; Li YJ; Jiang AQ; Yang MR; Zhu QZ; Dong H; Zhu HL
Eur J Med Chem; 2015 Apr; 94():447-57. PubMed ID: 25828827
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological evaluation of novel shikonin-benzo[b]furan derivatives as tubulin polymerization inhibitors targeting the colchicine binding site.
Shao YY; Yin Y; Lian BP; Leng JF; Xia YZ; Kong LY
Eur J Med Chem; 2020 Mar; 190():112105. PubMed ID: 32035399
[TBL] [Abstract][Full Text] [Related]
38. The discovery of novel indazole derivatives as tubulin colchicine site binding agents that displayed potent antitumor activity both in vitro and in vivo.
Cui YJ; Ma CC; Zhang CM; Tang LQ; Liu ZP
Eur J Med Chem; 2020 Feb; 187():111968. PubMed ID: 31865012
[TBL] [Abstract][Full Text] [Related]
39. Discovery of potent microtubule-destabilizing agents targeting for colchicine site by virtual screening, biological evaluation, and molecular dynamics simulation.
Zhang H; Luo QQ; Hu ML; Wang N; Qi HZ; Zhang HR; Ding L
Eur J Pharm Sci; 2023 Jan; 180():106340. PubMed ID: 36435355
[TBL] [Abstract][Full Text] [Related]
40. Development of S-aryl dithiocarbamate derived novel antiproliferative compound exhibiting tubulin bundling.
Jaiswal S; Parida SK; Murarka S; Singh P
Bioorg Med Chem; 2022 Aug; 68():116874. PubMed ID: 35716589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]